Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
0Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
Indivior Pharmaceuticals, Inc. (INDV) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
3Total relationships
1Distinct source URLs
3High confidence
0.900Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Indivior Pharmaceuticals, Inc. Suppliers
Ticker
Name
Confidence
Evidence
COUNTERPARTY-BANK
COUNTERPARTY-BANK
90%
The Company paid the Prepayment Amount to the Counterparty Bank and received an initial delivery of 3,717,473 shares.
Indivior Pharmaceuticals, Inc. Customers
No clients on recordIndivior Pharmaceuticals, Inc. does not appear to disclose named customer relationships in its verified regulatory filings. Many companies do not publicly name customers in regulatory disclosures.
Indivior Pharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
INDV-DEBT
Debt stack $487.0M
90%
Market cache reports total debt of $487.0M.
Indivior Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Indivior Pharmaceuticals, Inc..
Indivior Pharmaceuticals, Inc. Ownership
Holder
Name
Confidence
Evidence
INDV-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 11 tracked holders.
Indivior Pharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
